Carlo Maria Cipolla
Overview
Explore the profile of Carlo Maria Cipolla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fabiani I, Chianca M, Cipolla C, Cardinale D
Nat Rev Cardiol
. 2025 Jan;
PMID: 39875555
Anthracyclines are the cornerstone of treatment for many malignancies. However, anthracycline cardiotoxicity is a considerable concern given that it can compromise the clinical effectiveness of the treatment and patient survival...
2.
Camilli M, Cipolla C, Dent S, Minotti G, Cardinale D
JACC CardioOncol
. 2024 Oct;
6(5):655-677.
PMID: 39479333
Since their introduction in the 1960s, anthracyclines have been a significant breakthrough in oncology, introducing dramatic changes in the treatment of solid and hematologic malignancies. Although new-generation targeted drugs and...
3.
Fabiani I, Chianca M, Aimo A, Emdin M, Dent S, Fedele A, et al.
Eur Heart J
. 2024 Apr;
45(22):1971-1987.
PMID: 38591670
The last decade has witnessed a paradigm shift in cancer therapy, from non-specific cytotoxic chemotherapies to agents targeting specific molecular mechanisms. Nonetheless, cardiovascular toxicity of cancer therapies remains an important...
4.
Faggiano A, Gherbesi E, Avagimyan A, Ruscica M, Donisi L, Fedele M, et al.
Front Cardiovasc Med
. 2023 Dec;
10:1289384.
PMID: 38075951
Background: Oxidative stress induced by the excessive production of reactive oxygen species is one of the primary mechanisms implicated in anthracycline (ANT)-induced cardiotoxicity. There is a strong clinical need for...
5.
Morfino P, Aimo A, Castiglione V, Chianca M, Vergaro G, Cipolla C, et al.
Front Cardiovasc Med
. 2023 Jul;
10:1212983.
PMID: 37476571
Amyloid light-chain (AL) amyloidosis is a hematological disorder characterized by abnormal proliferation of a plasma cell clone producing monoclonal free light chains that misfold and aggregate into insoluble fibrils in...
6.
Chianca M, LAbbate S, Fabiani I, Aimo A, Emdin M, Passino C, et al.
Expert Opin Drug Metab Toxicol
. 2023 Mar;
19(2):109-119.
PMID: 36989398
Introduction: Human epidermal growth factor receptor two (HER2) target therapies have drastically revolutionized the treatment of HER2-positive breast cancer. Starting with trastuzumab, early phase III trials have already highlighted its...
7.
Garibaldi S, Chianca M, Fabiani I, Emdin M, Piacenti M, Passino C, et al.
J Clin Med
. 2022 Aug;
11(15).
PMID: 35956068
Longer life expectancy along with advancements in cancer and atrial fibrillation (AF) therapies and treatment strategies have led to an increase in the number of individuals with both diseases. As...
8.
Chianca M, Fabiani I, Del Franco A, Grigoratos C, Aimo A, Panichella G, et al.
Eur J Prev Cardiol
. 2022 Aug;
29(17):2163-2172.
PMID: 35938306
Since the introduction of anthracyclines into clinical practice in the 1960s, chemotherapy has always been associated with cardiotoxicity. Patients on cardiotoxic drugs can develop a wide range of cardiovascular diseases,...
9.
Chianca M, Panichella G, Fabiani I, Giannoni A, LAbbate S, Aimo A, et al.
Front Cardiovasc Med
. 2022 Jul;
9:936654.
PMID: 35872912
Cancer and heart failure are the two leading causes of death in developed countries. These two apparently distinct clinical entities share similar risk factors, symptoms, and pathophysiological mechanisms (inflammation, metabolic...
10.
Semeraro G, Cipolla C, Cardinale D
Cancers (Basel)
. 2021 Nov;
13(21).
PMID: 34771589
In patients with cancer-and especially some specific subtypes-the heart can be pathologically affected due to the direct action of the tumor or its secretion products or due to the toxicity...